Sunny Pharmtech Inc. engages in the research, development, and sale of new and generic drug formulations and raw materials in Taiwan, the United States, and internationally. It offers lidocaine ointment that can be used as an anesthetic lubricant for intubation, which temporarily relieves pain associated with minor burns, sunburn, skin abrasions, and insect bites; cyanocobalamin injection for use in vitamin B12 deficiency and pernicious anemia caused by malabsorption; nitrofurantoin capsules for urinary tract infection; and aminocaproic acid tablets for blood diseases and hyper-proteolytic enzymes. It also provides carboprost tromethamine injection for therapeutic abortion and postpartum hemorrhage, as well as Cyclophosphamide injection for malignant diseases. The company was founded in 2014 and is based in Taoyuan City, Taiwan.
Frequently asked questions
What sector does Sunny Pharmtech Inc. (6676) operate in?
Sunny Pharmtech Inc. belongs to the Other sector and operates in the Biotechnology industry.
What is Sunny Pharmtech Inc. (6676) current stock price?
As of the latest data, Sunny Pharmtech Inc. stock price is NT$12.50, with a previous close of NT$12.15. Sunny Pharmtech Inc. gained NT$0.35 in the last trading session, representing a 2.88% increase.
What is Sunny Pharmtech Inc. (6676) current market capitalization?
Sunny Pharmtech Inc. market cap is approximately 2.12 billion.
What is Sunny Pharmtech Inc. (6676) Earnings Per Share (EPS)?
The trailing EPS is -NT$2.03.
Does Sunny Pharmtech Inc. (6676) pay dividends?
No. Sunny Pharmtech Inc. does not pay a dividend.
What is Sunny Pharmtech Inc. (6676) beta (volatility) score?
Sunny Pharmtech Inc. has a beta of 0.292, indicating lower volatility than the overall market.
